Board of Managing Directors
Hubertus von Baumbach
Chairman of the Board of Managing Directors
Law degree and second state exam, MBA
Professional milestones
2012 – 2016 Member of the Board of Managing Directors with responsibility for Finance, Boehringer Ingelheim
2009 – 2012 Member of the Board of Managing Directors with responsibility for Finance and Animal Health, Boehringer Ingelheim
2006 – 2008 Vice President Finance, Boehringer Ingelheim Deutschland
2003 – 2005 Head of department Controlling Subsidiaries, Boehringer Ingelheim
2002 – 2003 Head of group Controlling CHC, Boehringer Ingelheim
Since 2001 Employee of Boehringer Ingelheim
| Carinne BrouillonMember of the Board of Managing Directors with responsibility for the Human Pharma Business Unit |
*5 June 1965
Doctor of Pharmacy Degree and MBA
Professional milestones
2018 – 2019 Global Head of Therapeutic Areas, Boehringer Ingelheim
2014 – 2018 Head of Global Commercial Strategy Neuroscience at Janssen, Johnson & Johnson’s Pharmaceutical Company
2012 – 2018 President of Janssen Therapeutics and Member of the Janssen North America Leadership Team
1997 – 2012 Various positions in sales, marketing and general management at Johnson & Johnson, EMEA (Europe, Middle East, Africa)
| Dr Paola CasarosaMember of the Board of Managing Directors with responsibility for the Innovation Unit |
*2 February 1974
PhD in Molecular Pharmacology, Vrije Universiteit Amsterdam, The Netherlands
MSc in Medicinal Chemistry, Università di Torino, Italy
Professional milestones
2020 – 2023 Global Head of Therapeutic Areas
2019 - 2020 Global Therapeutic Area Head CNS, Retinopathy and Emerging areas
2019 - Head of Research Site Biberach, Germany
2014 - 2018 Global Head of Business Development, Prescription Medicine
2013 - 2014 Head of Therapeutic Alliances and Strategic Partnerships
2010 - 2013 Global Head Business Development and Licensing for Respiratory
2004 - 2010 Various Research roles at Boehringer Ingelheim and Organon (MSD)
| Shashank DeshpandeMember of the Board of Managing Directors with responsibility for the Animal Health business |
*1 April 1973
Diplom-Kaufmann (Masters’ degree in Business Administration), University of Hamburg, Hamburg, Germany
Professional milestones
2022 - 2023 Country Managing Director, Japan
2020 - 2022 Head of Human Pharma, Japan
2019 - 2020 Head of Specialty Care, Japan
2017 - 2019 Head of Marketing, Japan
2014 - 2017 Head of Diabetes Marketing, Japan
2012 - 2014 Global Brand Team Leader Trajenta® (Ingelheim, Germany)
2002 - 2012 Various roles in US and Global Marketing at Sanofi, US
1999 - 2002 Strategy consultant at Cap Gemini, Germany
| Michael SchmelmerMember of the Board of Managing Directors with responsibility for Finance & Group Functions |
*17 June 1964
Master Degree in Aerospace Technologies and Mechanical Engineering, Master Degree in Industrial Engineering
Professional milestones
2016 – today Founder and Managing Director of BI X, the digital lab of Boehringer Ingelheim
2012 – 2017 CIO, Corporate Senior Vice President Information Technology, Boehringer Ingelheim
2006 – 2012 Corporate Vice President IT & CIO, Infineon AG
2003 – 2006 Vice President IT Business Transformation, Infineon AG
2000 – 2003 Vice President Logistics & Supply Chain Management IT Systems, Infineon AG
1999 – 2000 Senior Director of Supply Chain Management Competence Center IT, Infineon AG
| Frank HüblerMember of the Board of Managing Directors |
* July 18, 1971
Master of Science degree in Business Administration
from the Catholic University Eichstätt, Ingolstadt, Germany
Professional milestones
2019 – present Head of Corporate Finance, Accounting, Controlling & Tax
2017 – 2019 Head of Corporate Controlling
2015 – 2017 Project Leadership Boehringer Ingelheim CHC/ Sanofi Merial swap transaction
2013 – 2015 Head of Global Reporting & Planning
2011 – 2013 Head of Finance & Administration UK & Ireland, Bracknell, UK
2007 – 2011 Head of Controlling Regional Center Vienna, Vienna, Austria
2005 – 2007 Senior Manager Internal Auditing, Burlington, Canada